Ignite Creation Date:
2024-05-06 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05218603
Status:
RECRUITING
Last Update Posted:
2022-09-16
First Post:
2022-01-17
Brief Title:
Evaluation of Maintenance With Bortezomib Plus Daratumumab V-Dara After Induction With Bortezomib Melphalan Prednisone Plus Daratumumab VMP-Dara in Newly Diagnosed Multiple Myeloma MM Patients Non-eligible for autoSCT
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
GEM-OPTIMAL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen LP | INDUSTRY |
| Adknoma Health Research | INDUSTRY |